Study Shows Positive Long-Term Impact
BAT has published the full results from a year-long study, which show the positive long-term impact of switching from cigarettes to glo, BAT’s flagship Tobacco Heating Product
-
by Dave Cross
Share on:
The full findings, which have been published in Internal and Emergency Medicine, build upon the favourable changes reported at three and six-months. The improvements observed were sustained over the 12 months of the study, adding to the weight of evidence that supports glo as a less risky alternative for adult smokers who would not otherwise quit.
Dr David O’Reilly, Director, Scientific Research at BAT, said: “The results from this study are the most important data we have ever generated about glo and for the THP category in general. This real-world study allows us to assess the changes that adult smokers switching exclusively to glo experience, by assessing early indicators of potential harm associated with disease development. It provides much needed new evidence about the size of the change and durability of the effect switching completely to glo can have and reinforces glo’s potential as a reduced-risk product.
“I’d like to thank everyone who participated in and helped deliver this study. It is another important step forward in our journey to building A Better Tomorrow.”
Based on the early indicators of disease measured, smokers who switched completely to glo instead of continuing to smoke showed:
- Significant and sustained reduction in a biomarker with the potential to cause DNA damage associated with lung cancer
- Significant and sustained reduction in white blood cell count, an inflammatory marker associated with early development of CVD and other smoking-related diseases
- Sustained improvement in HDL cholesterol associated with reduced development of CVD
- Significant and sustained improvement in an indicator of lung health (FeNO)
- Significant and sustained improvement in a key indicator of oxidative stress, a process implicated in several smoking-related diseases, such as CVD
These new data build on the findings of another recent publication about glo, which concluded that “given the accumulated scientific data, glo is a reduced exposure product compared to combustible cigarettes and is reasonably deemed to reduce the risk of smoking-related diseases and supports the conclusion that smokers who switch entirely to THP glo use, will reduce their relative risk of developing smoking-related diseases as compared to continued smoking.”
References:
- Changes in biomarkers of exposure and biomarkers of potential harm after 360 days in smokers who either continue to smoke, switch to a tobacco heating product or quit smoking - https://link.springer.com/article/10.1007/s11739-022-03062-1
Dave Cross
Journalist at POTVDave is a freelance writer; with articles on music, motorbikes, football, pop-science, vaping and tobacco harm reduction in Sounds, Melody Maker, UBG, AWoL, Bike, When Saturday Comes, Vape News Magazine, and syndicated across the Johnston Press group. He was published in an anthology of “Greatest Football Writing”, but still believes this was a mistake. Dave contributes sketches to comedy shows and used to co-host a radio sketch show. He’s worked with numerous vape companies to develop content for their websites.
Join the discussion
Harm Reduction For The Rich
The United Kingdom risks becoming a harm reduction country only for the wealthy, according to Michael Landl of the World Vapers’ Alliance
-
by Dave Cross
CAPHRA Highlights Tobacco Control Flaws
The Coalition of Asia Pacific Tobacco Harm Reduction Advocates highlights the flaws in tobacco control which has led to the rise of black market in Australia
-
by Dave Cross
A Missed Opportunity at COP10
The Smoke Free Sweden movement says that COP10 was a missed opportunity to save millions of lives
-
by Dave Cross
COP10: Promote Tobacco Harm Reduction
Experts with Smoke Free Sweden are emphasising the urgent need for a Tobacco Harm Reduction approach at COP10
-
by Dave Cross
